Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal

Volumn 19, Issue 5, 2013, Pages 639-643

  Wang, Jin Ye ^a,b   Wang, Kai ^a   Chen, Xian Wen ^a   Wang, Jian Wen ^b   Zhang, Kan ^b   Xu, Ming Wei ^b   Luo, Ben Yan ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

AQP 4 antibody; brain lesions; meningoencephalitis; myelitis; NMO spectrum disorder; optic neuritis

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; METHYLPREDNISOLONE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BRAIN DAMAGE; CASE REPORT; CERVICAL SPINAL CORD INJURY; COLOR BLINDNESS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; MENINGOENCEPHALITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; STEROID THERAPY; TUBERCULOSIS; VISUAL IMPAIRMENT; WEAKNESS;

EID: 84876526516     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512459785     Document Type: Article

References (13)

1. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
2. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 ; 78: 665-671
3. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815
4. Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009 ; 66: 425-428
5. Banker P, Sonni S, Kister I, et al. Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler. 2012 ; 18: 1050-1053
6. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112
7. Kim SH, Kim W, Li XF, et al. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012 ; 78: 1179-1185
8. Downer JJ, Leite MI, Carter R, et al. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?. Neuroradiology. 2012 ; 54: 279-285
9. Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler. 2010 ; 16: 1229-1236
10. Kim W, Kim SH, Lee SH, et al. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler. 2011 ; 17: 1107-1111
11. Chan KH, Tse CT, Chung CP, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol. 2011 ; 68: 1432-1439
12. Sato D, Fujihara K.. Atypical presentations of neuromyelitis optica. Arq Neuropsiquiatr. 2011 ; 69: 824-828
13. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010 ; 17: 1019-1032